Published in Mol Cell Proteomics on December 07, 2016
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res (2010) 18.73
Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38
Novel cell death program leads to neutrophil extracellular traps. J Cell Biol (2007) 10.92
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell (2009) 8.21
2016 update of the PRIDE database and its related tools. Nucleic Acids Res (2015) 5.14
The human keratins: biology and pathology. Histochem Cell Biol (2008) 5.13
Keratin expression in human tissues and neoplasms. Histopathology (2002) 4.91
MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res (2011) 4.90
Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu Rev Biochem (2004) 3.30
Driving ribosome assembly. Biochim Biophys Acta (2009) 3.14
Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med (2010) 2.44
Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res (2011) 2.40
Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One (2010) 2.32
Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A (2012) 2.23
MS-GF+ makes progress towards a universal database search tool for proteomics. Nat Commun (2014) 2.22
Tumor-associated neutrophils: friend or foe? Carcinogenesis (2012) 2.15
Proteolytic networks in cancer. Trends Cell Biol (2011) 2.10
Tumor associated macrophages and neutrophils in cancer. Immunobiology (2013) 1.87
Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med (2001) 1.72
Clinical utility of cytokeratins as tumor markers. Clin Biochem (2004) 1.63
Keratins in health and cancer: more than mere epithelial cell markers. Oncogene (2010) 1.61
Keratin expression in endocrine organs and their neoplasms. Endocr Pathol (2009) 1.54
Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol (2013) 1.49
Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res (2004) 1.42
Cytokeratin markers come of age. Tumour Biol (2007) 1.28
Noncaspase proteases in apoptosis. Leukemia (2000) 1.27
Tools for label-free peptide quantification. Mol Cell Proteomics (2012) 1.27
Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res (2009) 1.25
Protease signalling: the cutting edge. EMBO J (2012) 1.24
Neutrophils in innate and adaptive immunity. Semin Immunopathol (2013) 1.23
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest (2005) 1.20
Proteomic analyses reveal an acidic prime side specificity for the astacin metalloprotease family reflected by physiological substrates. Mol Cell Proteomics (2011) 1.20
Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J Biol Chem (2001) 1.18
Secretion of human meprin from intestinal epithelial cells depends on differential expression of the alpha and beta subunits. Eur J Biochem (1999) 1.15
Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response. Cancer Res (2012) 1.12
Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics (2010) 1.12
The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Cancer Res (2003) 1.11
Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker. EMBO J (1984) 1.09
Neutrophils in cancer: neutral no more. Nat Rev Cancer (2016) 1.06
Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem (1996) 1.06
Solution structure of the symmetric coiled coil tetramer formed by the oligomerization domain of hnRNP C: implications for biological function. J Mol Biol (2005) 1.05
Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics (2010) 1.04
PMAP: databases for analyzing proteolytic events and pathways. Nucleic Acids Res (2008) 1.03
A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol (2013) 1.02
The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol (2007) 1.01
Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase. PLoS One (2013) 1.00
The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines. Int J Cancer (2001) 1.00
Clathrin pit-mediated endocytosis of neutrophil elastase and cathepsin G by cancer cells. J Biol Chem (2012) 0.98
Shotgun proteome analysis of protein cleavage in apoptotic cells. Proteomics (2005) 0.96
An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. Proteomics Clin Appl (2009) 0.94
Proteome analysis of apoptotic cells. Mass Spectrom Rev (2004) 0.93
Neutrophil elastase as a target in lung cancer. Anticancer Agents Med Chem (2012) 0.92
Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients. Neoplasia (2007) 0.92
Free-form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer. J Leukoc Biol (1995) 0.91
Comprehensive analysis of the palindromic motif TCTCGCGAGA: a regulatory element of the HNRNPK promoter. DNA Res (2010) 0.90
Neutrophils in the Tumor Microenvironment. Trends Immunol (2015) 0.89
Quantitative proteome analysis of cisplatin-induced apoptotic Jurkat T cells by stable isotope labeling with amino acids in cell culture, SDS-PAGE, and LC-MALDI-TOF/TOF MS. Electrophoresis (2007) 0.89
From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade. Biomark Med (2012) 0.89
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res (2013) 0.88
Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of α1-antitrypsin in lung cancer. Mol Oncol (2012) 0.87
Enhanced activity of meprin-α, a pro-migratory and pro-angiogenic protease, in colorectal cancer. PLoS One (2011) 0.87
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer. Eur J Cancer (2010) 0.86
Cytokeratin fragments in the serum: their utility for the management of oral cancer. Oral Oncol (2008) 0.86
MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment. Int J Proteomics (2012) 0.85
The emerging role of serine proteases in apoptosis. Biochem Soc Trans (2007) 0.85
A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers. Cell Death Dis (2013) 0.85
Keratins in oral cancer: necessity of mass spectrometry for validation of antibody based identifications. J Proteomics (2012) 0.83
Monoclonal antibody Cam 5.2 targeted mainly CK8, but not CK18--Comment on: "Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation--report of a unique case. Int J Clin Exp Pathol. 2010 May 5; 3 (5):534-40.". Int J Clin Exp Pathol (2010) 0.81
Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers. Acta Biochim Pol (2013) 0.81
Cytokeratin serum biomarkers in patients with colorectal cancer. Anticancer Res (2012) 0.80
A SILAC-based approach identifies substrates of caspase-dependent cleavage upon TRAIL-induced apoptosis. Mol Cell Proteomics (2013) 0.80
Analysis of distinct molecular assembly complexes of keratin K8 and K18 by hydrogen-deuterium exchange. J Struct Biol (2015) 0.79
Monoclonal antibody CAM5.2 can detect the cytokeratin 8, not cytokeratin 18. Comment on: "Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance. Langenbecks Arch Surg. 2009 Jan; 394(1): 105-113.". Langenbecks Arch Surg (2010) 0.79
Crystal structure and functional characterization of the human RBM25 PWI domain and its flanking basic region. Biochem J (2013) 0.77
Gradient Infiltration of Neutrophil Extracellular Traps in Colon Cancer and Evidence for Their Involvement in Tumour Growth. PLoS One (2016) 0.77
Proteomic analysis of colon and rectal carcinoma using standard and customized databases. Sci Data (2015) 0.76
Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma. Urol Int (2011) 0.76
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera. J Proteome Res (2016) 0.76
High precision quantification of human plasma proteins using the automated SISCAPA Immuno-MS workflow. N Biotechnol (2016) 0.75